Who to call at Traws Pharma, Inc., and when
Fundz watches for the moments Traws Pharma, Inc. starts buying, and tells you who to reach.
- An alert the day Traws Pharma, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Traws Pharma, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Traws Pharma, Inc.. With Fundz connected, it knows.
Traws Pharma, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
onconova.comAI Executive Summary
AI-powered analysis of 8-K filing content
At its November 21, 2025 annual meeting, Traws Pharma stockholders approved an amended and restated 2021 Incentive Compensation Plan that adds 1,500,000 shares to the reserve and extends the plan through November 20, 2035. The change expands the equity pool available for employee and director compensation, which can create future dilution for existing holders.
Key Takeaways
Stockholders approved an increase of 1,500,000 shares in the reserve under the Amended and Restated 2021 Incentive Compensation Plan, effective November 21, 2025.
The plan term was extended to November 20, 2035, giving the company a longer runway to grant equity awards.
3 more takeaways
Related Filings (20)
20 more filings from Traws Pharma, Inc. in the last 90 days
Filing Overview
What This Means
Traws Pharma, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.